"","submission_name","submission_date","template_name","tissue_type","response_component_original","response_comp_orig_cnt","response_component","response_comp_cnt","response_behavior_type","response_behavior","comparison","subgroup","time_point","time_point_units","baseline_time","target_pathogen","vaccine_year","exposure_material","additional_exposure_material","cohort","adjuvant","route","publication_reference","publication_year","signature_source","signature_source_url","comments","is_model","publication_reference_url","age_group","age_min","age_max","age_units","subm_obs_id","uniq_obs_id","row_key","signature_file","signature_file_complete"
"subject","","","","cell_subset","","","gene","","","","","","","","","pathogen","","vaccine","","","","","","","","","","","","","","","","","","","",""
"evidence","","","","","label","label","","label","label","label","label","label","label","label","label","","label","","label","label","label","label","label","label","label","label","label","label","url","label","label","label","label","label","label","label","file","file"
"role","","","","tissue","observed","observed","gene_biomarker","observed","background","measured","background","background","observed","observed","background","pathogen","background","vaccine","background","observed","background","background","background","background","background","background","background","background","reference","observed","observed","observed","observed","background","background","background","observed","observed"
"mime_type","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"numeric_units","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","","",""
"display_text","","","","tissue type","response component (original gene symbol)","response component (original) count","response component (gene symbol)","response component count","response behavior type","response behavior","comparison","subgroup","time point","time point units","baseline time","target pathogen","vaccine year (influenza only)","exposure material (VO)","exposure material - additional","cohort","adjuvant","route","publication reference (PMID)","publication year","signature source figure, table or text section","signature source url","comments and additional details","gene signature is a model","Sobolev et al. (2016) Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events. Nat Immunol. PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=26726811' target='_blank'>26726811</a>","age group","age min.","age max.","age units","ID of observation within its own submission","Uniq ID of observation within its submission type","row key","response component (genes) file"," response components including non-HGNC genes"
"","hipc_gene_26726811_7","2016.02","hipc_gene_26726811_7","peripheral blood mononuclear cell","LRRC75B","10","LRRC75B","10","gene expression","up-regulated","high vs low responders","medium-high adverse events score","1","Day","time of vaccination (first dose)","influenza A virus (A/California/7/2009(H1N1))","pan","VO_0000410","","adults (18-64)","","","26726811","2016","Fig 5e","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F5/' target='_blank'>figure/F5</a>","High AE individuals show day +1 and pre-vaccine differences to asymptomatic study subjects. (e) Genes expressed differentially in low AE vs medium/high AE study subjects on post-vaccine day +1","N","https://www.ncbi.nlm.nih.gov/pubmed/26726811","adults, seniors","18","64","years","7","58","26726811_7_58","hipc_gene_sig_26726811_7.txt","hipc_gene_sig_complete_26726811_7.txt"
"","hipc_gene_26726811_7","2016.02","hipc_gene_26726811_7","peripheral blood mononuclear cell","LNX2","10","LNX2","10","gene expression","up-regulated","high vs low responders","medium-high adverse events score","1","Day","time of vaccination (first dose)","influenza A virus (A/California/7/2009(H1N1))","pan","VO_0000410","","adults (18-64)","","","26726811","2016","Fig 5e","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F5/' target='_blank'>figure/F5</a>","High AE individuals show day +1 and pre-vaccine differences to asymptomatic study subjects. (e) Genes expressed differentially in low AE vs medium/high AE study subjects on post-vaccine day +1","N","https://www.ncbi.nlm.nih.gov/pubmed/26726811","adults, seniors","18","64","years","7","58","26726811_7_58","hipc_gene_sig_26726811_7.txt","hipc_gene_sig_complete_26726811_7.txt"
"","hipc_gene_26726811_7","2016.02","hipc_gene_26726811_7","peripheral blood mononuclear cell","BCL2L14","10","BCL2L14","10","gene expression","up-regulated","high vs low responders","medium-high adverse events score","1","Day","time of vaccination (first dose)","influenza A virus (A/California/7/2009(H1N1))","pan","VO_0000410","","adults (18-64)","","","26726811","2016","Fig 5e","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F5/' target='_blank'>figure/F5</a>","High AE individuals show day +1 and pre-vaccine differences to asymptomatic study subjects. (e) Genes expressed differentially in low AE vs medium/high AE study subjects on post-vaccine day +1","N","https://www.ncbi.nlm.nih.gov/pubmed/26726811","adults, seniors","18","64","years","7","58","26726811_7_58","hipc_gene_sig_26726811_7.txt","hipc_gene_sig_complete_26726811_7.txt"
"","hipc_gene_26726811_7","2016.02","hipc_gene_26726811_7","peripheral blood mononuclear cell","PLAAT4","10","PLAAT4","10","gene expression","up-regulated","high vs low responders","medium-high adverse events score","1","Day","time of vaccination (first dose)","influenza A virus (A/California/7/2009(H1N1))","pan","VO_0000410","","adults (18-64)","","","26726811","2016","Fig 5e","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F5/' target='_blank'>figure/F5</a>","High AE individuals show day +1 and pre-vaccine differences to asymptomatic study subjects. (e) Genes expressed differentially in low AE vs medium/high AE study subjects on post-vaccine day +1","N","https://www.ncbi.nlm.nih.gov/pubmed/26726811","adults, seniors","18","64","years","7","58","26726811_7_58","hipc_gene_sig_26726811_7.txt","hipc_gene_sig_complete_26726811_7.txt"
"","hipc_gene_26726811_7","2016.02","hipc_gene_26726811_7","peripheral blood mononuclear cell","KRT9","10","KRT9","10","gene expression","up-regulated","high vs low responders","medium-high adverse events score","1","Day","time of vaccination (first dose)","influenza A virus (A/California/7/2009(H1N1))","pan","VO_0000410","","adults (18-64)","","","26726811","2016","Fig 5e","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F5/' target='_blank'>figure/F5</a>","High AE individuals show day +1 and pre-vaccine differences to asymptomatic study subjects. (e) Genes expressed differentially in low AE vs medium/high AE study subjects on post-vaccine day +1","N","https://www.ncbi.nlm.nih.gov/pubmed/26726811","adults, seniors","18","64","years","7","58","26726811_7_58","hipc_gene_sig_26726811_7.txt","hipc_gene_sig_complete_26726811_7.txt"
"","hipc_gene_26726811_7","2016.02","hipc_gene_26726811_7","peripheral blood mononuclear cell","CNDP2","10","CNDP2","10","gene expression","up-regulated","high vs low responders","medium-high adverse events score","1","Day","time of vaccination (first dose)","influenza A virus (A/California/7/2009(H1N1))","pan","VO_0000410","","adults (18-64)","","","26726811","2016","Fig 5e","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F5/' target='_blank'>figure/F5</a>","High AE individuals show day +1 and pre-vaccine differences to asymptomatic study subjects. (e) Genes expressed differentially in low AE vs medium/high AE study subjects on post-vaccine day +1","N","https://www.ncbi.nlm.nih.gov/pubmed/26726811","adults, seniors","18","64","years","7","58","26726811_7_58","hipc_gene_sig_26726811_7.txt","hipc_gene_sig_complete_26726811_7.txt"
"","hipc_gene_26726811_7","2016.02","hipc_gene_26726811_7","peripheral blood mononuclear cell","RMI2","10","RMI2","10","gene expression","up-regulated","high vs low responders","medium-high adverse events score","1","Day","time of vaccination (first dose)","influenza A virus (A/California/7/2009(H1N1))","pan","VO_0000410","","adults (18-64)","","","26726811","2016","Fig 5e","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F5/' target='_blank'>figure/F5</a>","High AE individuals show day +1 and pre-vaccine differences to asymptomatic study subjects. (e) Genes expressed differentially in low AE vs medium/high AE study subjects on post-vaccine day +1","N","https://www.ncbi.nlm.nih.gov/pubmed/26726811","adults, seniors","18","64","years","7","58","26726811_7_58","hipc_gene_sig_26726811_7.txt","hipc_gene_sig_complete_26726811_7.txt"
"","hipc_gene_26726811_7","2016.02","hipc_gene_26726811_7","peripheral blood mononuclear cell","METTL6","10","METTL6","10","gene expression","up-regulated","high vs low responders","medium-high adverse events score","1","Day","time of vaccination (first dose)","influenza A virus (A/California/7/2009(H1N1))","pan","VO_0000410","","adults (18-64)","","","26726811","2016","Fig 5e","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F5/' target='_blank'>figure/F5</a>","High AE individuals show day +1 and pre-vaccine differences to asymptomatic study subjects. (e) Genes expressed differentially in low AE vs medium/high AE study subjects on post-vaccine day +1","N","https://www.ncbi.nlm.nih.gov/pubmed/26726811","adults, seniors","18","64","years","7","58","26726811_7_58","hipc_gene_sig_26726811_7.txt","hipc_gene_sig_complete_26726811_7.txt"
"","hipc_gene_26726811_7","2016.02","hipc_gene_26726811_7","peripheral blood mononuclear cell","TGM2","10","TGM2","10","gene expression","up-regulated","high vs low responders","medium-high adverse events score","1","Day","time of vaccination (first dose)","influenza A virus (A/California/7/2009(H1N1))","pan","VO_0000410","","adults (18-64)","","","26726811","2016","Fig 5e","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F5/' target='_blank'>figure/F5</a>","High AE individuals show day +1 and pre-vaccine differences to asymptomatic study subjects. (e) Genes expressed differentially in low AE vs medium/high AE study subjects on post-vaccine day +1","N","https://www.ncbi.nlm.nih.gov/pubmed/26726811","adults, seniors","18","64","years","7","58","26726811_7_58","hipc_gene_sig_26726811_7.txt","hipc_gene_sig_complete_26726811_7.txt"
"","hipc_gene_26726811_7","2016.02","hipc_gene_26726811_7","peripheral blood mononuclear cell","IDO1","10","IDO1","10","gene expression","up-regulated","high vs low responders","medium-high adverse events score","1","Day","time of vaccination (first dose)","influenza A virus (A/California/7/2009(H1N1))","pan","VO_0000410","","adults (18-64)","","","26726811","2016","Fig 5e","<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485475/figure/F5/' target='_blank'>figure/F5</a>","High AE individuals show day +1 and pre-vaccine differences to asymptomatic study subjects. (e) Genes expressed differentially in low AE vs medium/high AE study subjects on post-vaccine day +1","N","https://www.ncbi.nlm.nih.gov/pubmed/26726811","adults, seniors","18","64","years","7","58","26726811_7_58","hipc_gene_sig_26726811_7.txt","hipc_gene_sig_complete_26726811_7.txt"
